Santa Cruz, CA, United States of America

Marco Blanchette

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Marco Blanchette: Innovator in Genomic Technologies

Introduction

Marco Blanchette is a prominent inventor based in Santa Cruz, CA, known for his significant contributions to genomic technologies. With a total of 5 patents, he has made strides in the field of genome assembly and haplotype phasing.

Latest Patents

One of his latest patents is focused on the generation of phased read-sets for genome assembly and haplotype phasing. This patent discloses methods, compositions, and systems that facilitate accurate phasing of sequence data, such as genomic sequence data. The methods involve the segmentation and rearrangement of nucleic acid molecules to preserve individual molecules' phase or physical linkage information. This is achieved by binding molecules independent of their phosphodiester backbones, cleaving the molecules, ligating, and sequencing them through long-read sequencing technology to recover segment sequence information spanning multiple segments. Another notable patent is related to sample preparation for DNA linkage recovery. This patent provides methods for releasing nucleic acids from a fixed biological sample by contacting the fixed tissue sample with an enzyme. It also includes methods to quantify and deconvolute a population of mRNA spliced variant isoforms from a cellular transcriptome, as well as methods for delivering a barcode to a nucleic acid sample using integrases.

Career Highlights

Marco currently works at Dovetail Genomics, LLC, where he continues to innovate in the field of genomics. His work has been instrumental in advancing the understanding and manipulation of genetic materials.

Collaborations

He collaborates with notable colleagues, including Paul Hartley and Christopher John Troll, who contribute to the innovative environment at Dovetail Genomics.

Conclusion

Marco Blanchette's work in genomic technologies exemplifies the impact of innovation in the field of genetics. His patents and collaborations highlight his commitment to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…